Current Studies

Our center is primarily involved in Phase II, Phase III, and Phase IV studies. Phase 2 studies are primarily focused on safety. Once a drug has proven safe after many years of study, a phase-III trial is undertaken to test its effectiveness in treating a symptom or disease. This is the final phase before FDA approval and use by the public. Phase IV studies take place after a drug is on the market. It retests safety issues.

Certain studies measure the effect of a medication on a symptom or disease versus that of a placebo (an inactive product). Neither Dr. Werner, the study staff, nor you would know if you are receiving the study medication or the placebo. In other studies, everyone receives a medication, and no placebos are involved.

The following is a list of studies currently being performed:

• Oral testosterone undecanoate in hypogonadal men
• Healthy female subjects with hypoactive sexual desire disorder and low sensitivity for sexual cues
• Peyronie's disease (Enrollment closed)
• Secondary hypogonadism in men (Enrollment closed)

For more information please contact us at studies@mazelabs.com.